收藏切换
Cardiac Piezo1 Exacerbates Lethal Ventricular Arrhythmogenesis by Linking Mechanical Stress with Ca2+ Handling After Myocardial Infarction
收藏切换
PDF
Sheng-an Su1, Yuhao Zhang2, Wudi Li1, Yutao Xi3, Yunrui Lu1, Jian Shen1, Yuankun Ma1, Yaping Wang2, Yimin Shen1, Lan Xie1, Hong Ma1, Yao Xie1, *, Meixiang Xiang1, *
Research. Vol 6 Article ID 0165
Less
收藏切换
Research. Vol 6 Article ID 0165
• Research Article •
Cardiac Piezo1 Exacerbates Lethal Ventricular Arrhythmogenesis by Linking Mechanical Stress with Ca2+ Handling After Myocardial Infarction
Full
Sheng-an Su1, Yuhao Zhang2, Wudi Li1, Yutao Xi3, Yunrui Lu1, Jian Shen1, Yuankun Ma1, Yaping Wang2, Yimin Shen1, Lan Xie1, Hong Ma1, Yao Xie1, *, Meixiang Xiang1, *
Affiliations
  • 1Department of Cardiology, Cardiovascular Key Laboratory of Zhejiang Province, The Second Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou 310009, China.
  • 2Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
  • 3Texas Heart Institute, Houston, TX 77030, USA.
About Author:

† These authors contributed equally to this work.

Published: 2023-06-20 doi: 10.34133/research.0165
Outline
收藏切换

Ventricular arrhythmogenesis is a key cause of sudden cardiac death following myocardial infarction (MI). Accumulating data show that ischemia, sympathetic activation, and inflammation contribute to arrhythmogenesis. However, the role and mechanisms of abnormal mechanical stress in ventricular arrhythmia following MI remain undefined. We aimed to examine the impact of increased mechanical stress and identify the role of the key sensor Piezo1 in ventricular arrhythmogenesis in MI. Concomitant with increased ventricular pressure, Piezo1, as a newly recognized mechano-sensitive cation channel, was the most up-regulated mechanosensor in the myocardium of patients with advanced heart failure. Piezo1 was mainly located at the intercalated discs and T-tubules of cardiomyocytes, which are responsible for intracellular calcium homeostasis and intercellular communication. Cardiomyocyte-conditional Piezo1 knockout mice (Piezo1Cko) exhibited preserved cardiac function after MI. Piezo1Cko mice also displayed a dramatically decreased mortality in response to the programmed electrical stimulation after MI with a markedly reduced incidence of ventricular tachycardia. In contrast, activation of Piezo1 in mouse myocardium increased the electrical instability as indicated by prolonged QT interval and sagging ST segment. Mechanistically, Piezo1 impaired intracellular calcium cycling dynamics by mediating the intracellular Ca2+ overload and increasing the activation of Ca2+-modulated signaling, CaMKII, and calpain, which led to the enhancement of phosphorylation of RyR2 and further increment of Ca2+ leaking, finally provoking cardiac arrhythmias. Furthermore, in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), Piezo1 activation remarkably triggered cellular arrhythmogenic remodeling by significantly shortening the duration of the action potential, inducing early afterdepolarization, and enhancing triggered activity.This study uncovered a proarrhythmic role of Piezo1 during cardiac remodeling, which is achieved by regulating Ca2+ handling, implying a promising therapeutic target in sudden cardiac death and heart failure.

Sheng-an Su, Yuhao Zhang, Wudi Li, Yutao Xi, Yunrui Lu, Jian Shen, Yuankun Ma, Yaping Wang, Yimin Shen, Lan Xie, Hong Ma, Yao Xie, Meixiang Xiang. Cardiac Piezo1 Exacerbates Lethal Ventricular Arrhythmogenesis by Linking Mechanical Stress with Ca2+ Handling After Myocardial Infarction[J]. Research, 2023 , 6 (6) : 0165 - . DOI: 10.34133/research.0165
Despite the improved prognosis of cardiovascular diseases, the prevalence of sudden cardiac death (SCD) keeps rising. Coronary artery disease often leads to cardiac structural and electrical remodeling due to myocardial ischemia or infarction. Such extensive cardiac remodeling eventually precipitates pump failure and fatal ventricular arrhythmias. In the setting of myocardial infarction (MI), the structural and electrical remodeling initially helps in compensating cardiac performance. But over time, the persistent ischemia gradually elevated sympathetic tone, and ongoing inflammation caused progressive ventricular enlargement and fibrosis, leading to adverse alteration of cardiac mechanical properties including elevated end-diastolic pressure and so on [1]. Although it has been noted that increased ventricular pressure results in the appearance of early afterdepolarization (EAD) and potential electrical instability for decades [2], the direct linkage between mechanical stress and arrhythmia formation is still lacking. Meanwhile, ion channel-mediated electrical remodeling, including action potential and intracellular calcium cycling, contributes to ventricular arrhythmogenesis [3]. Thus, there has been a growing interest in mechano-modulated ion channel remodeling as a therapeutic target for MI with implications of heart failure and SCD.
The recently discovered protein Piezo1 is a mechanosensitive cation channel. It appears like a triskelion with an ionic pore in the middle, displaying nonselective cation permeability with a greater preference to Ca2+. It serves as a sensor to transduce mechanical forces into physiological effects via transmembrane Ca2+ flux [4,5]. The cardiovascular relevance of Piezo1 initially rises to prominence in endothelial responses to mechanical stress, with studies illustrating that endothelium–Piezo1 plays critical roles in vascular maturation [6,7] and blood pressure modulation [8,9]. Besides, the importance of smooth muscle Piezo1 in vascular remodeling is elegantly demonstrated. Piezo1 opening in smooth muscle cells leads to a rise in cytosolic Ca2+ and further activation of transglutaminases, showing a trophic effect on resistance arteries in hypertension [10]. Moreover, the expression of Piezo1 is not restricted to endothelial cells and smooth muscle cells. It has also been implicated in the mechanosensing of cardiac fibroblasts [11], cardiomyocytes [12,13], and inflammatory cells [14,15]. Recently, we and Xiao group have demonstrated that cardiac Piezo1 functions as a key component of mechanosensing machinery in regulating heart maturation and pathological hypertrophy [12,13]. Activated Piezo1 channel by mechanical stretching generates extracellular Ca2+ influx and provokes mechano-chemo-transduction including calcineurin/calpain and reactive oxygen species (ROS) pathway, which eventually leads to cardiomyopathy and heart failure. It may provide a novel promising therapeutic target for heart diseases.
Given the association between mechanical pressure and cardiac electrical instability, we hypothesize that Piezo1 may mediate mechanical stretch-induced arrhythmogenesis and adverse cardiovascular events following MI. Here, we investigate the relationship between Piezo1 expression and human heart dysfunction. By applying mouse genetics and pharmacological intervention, we aim to demonstrate the function of Piezo1 in cardiomyocytes after MI and explore its role in cardiac remodeling after myocardial injury.
Although Piezo1 is widely considered to be expressed in the cardiovascular system, its distribution among different cell types in the heart remains elusive. By re-analyzing the single-cell sequence data of the normal human adult heart [Gene Expression Omnibus (GEO) accession no: GSE109816] [16], we discovered that cardiomyocytes accounted for 38.2% of Piezo1+ cells in the human heart, one of the most abundant sources. The remaining Piezo1+ cells were distributed in endothelial cells (42.1%), fibroblasts (8.8%), smooth muscle cells (7.7%), and macrophages (2.2%) (Fig. 1A). In the human diseased hearts, the RNA-sequencing data from human failing hearts with dilated cardiomyopathy (DCM) (GEO accession no: GSE29819) showed that the mRNA level of Piezo1 was up-regulated in the failing heart, while Piezo2 expression and other key ion channels remained unchanged (Fig. 1B and Fig. S1A). To further validate these findings, we used immunohistochemical staining (Fig. 1C and D) and Western blotting (Fig. 1E and F) to confirm that Piezo1 was significantly increased in the myocardium of patients with advanced heart failure of DCM.
Cardiomyocytes are intertwined by intercalated discs and contract in synchronism to meet circulatory demands. Impairment of cell–cell interaction induces cardiomyopathy and pump failure [17]. Interestingly, we found that Piezo1 is mainly located at the intercalated discs and T-tubules by immunofluorescence staining (Fig. 2A), implying a potential role in regulating ventricular function. In the setting of the mouse MI model, Piezo1 expression decreased on day 3 after MI but gradually rose from 7 to 28 days after MI (Fig. 2B and C). To explore the contribution of cardiomyocyte Piezo1 during cardiac remodeling after MI, we crossed Piezo1fl/fl mice to Myh6-MerCreMer transgenic mice, generating cardiomyocyte conditional Piezo1 knockout mice (Piezo1Cko). Littermates not carrying the Myh6-Cre transgene (Piezo1fl/fl) served as controls. The deletion efficiency was confirmed in isolated adult cardiomyocytes (Fig. S1B). The basic cardiac function between the 2 groups showed no significant difference (Table S2). Assessed by echocardiography, cardiac Piezo1 deletion showed a protective role on cardiac function as evidenced by the slight decrease of ejection fraction (EF) from 36.43% ± 4.44% to 31.31% ± 5.73% between the 3rd day to the 6th week after MI, while EF prominently declined from 33.04% ± 2.69% to 18.64% ± 2.73% in the Piezo1fl/fl group (Fig. 2D and E and Table S3). In accompany with the alteration of EF, the fractional shortening (FS) was significantly maintained in the Piezo1Cko group, while it was obviously declined in the Piezo1fl/fl group (Fig. 2F). Notably, the interventricular septal thickness at diastole (IVS d) was preserved in the Piezo1Cko group but reduced in the Piezo1fl/fl group (Fig. 2G), while the thickness of the left ventricular posterior wall (LVPW d) was comparable between the 2 groups (Fig. 2H). Eventually, within prolonged time, the Piezo1fl/fl mice exhibited enlarged left ventricular volume at diastole (LV Vol d) and left ventricular internal diameter (LVID d) after MI (Fig. 2I and J). However, the left ventricular mass (LV Mass) was comparable between Piezo1Cko and Piezo1fl/fl mice subjected to infarction (Fig. 2K).
Fibrosis distorts the myocardial architecture by depositing excessive extracellular matrix (ECM) and exacerbates cardiac dysfunction following MI. To assess the extent of fibrosis after Piezo1 knockout, Sirius red staining was used. It was notable that the area of fibrotic scarring did not differ between the Piezo1fl/fl group and the Piezo1Cko group (Fig. 2L). Meanwhile, the mRNA expression levels of fibrotic genes, including MMP9, ACTA2, and TGFBR2, were comparable between the 2 groups (Fig. S2A to C).
Given that cardiac deletion of Piezo1 significantly preserved cardiac function without affecting ECM deposition after MI as shown above, we sought to examine whether Piezo1 deletion reserves myocyte contractility. First, the expression level of sarcoplasmic reticulum (SR) Ca2+-adenosine triphosphatase (ATPase) 2 (SERCA2) responsible for myocyte contraction was investigated. In accordance with the preserved cardiac function, the SERCA2 expression was dramatically retained in Piezo1Cko mice at week 6 after MI (Fig. 3A and B). SERCA2-mediated SR Ca2+ uptake is critical in regulating the excitation–contraction coupling of cardiomyocytes [18]. To further explore whether Piezo1 activation affects this process, the Ca2+ transient was assessed. At the myocyte level, basal Ca2+ transient amplitude and time constant of intracellular Ca2+ concentration decline (Tau), indicators of SR Ca2+-ATPase function, SR Ca2+ content, and Na+/Ca2+ exchange function, were not significantly altered between Piezo1Cko and Piezo1fl/fl groups. However, activation of Piezo1 by its agonist Yoda1 exhibited an obvious elevation of Ca2+ transient amplitude and a faster decline of intracellular Ca2+ concentration, which was highly suppressed in the Piezo1Cko mice (Fig. 3C to E). As well as Yoda1, another novel agonist of Piezo1, Jedi1 [19] exhibited a moderate elevation of Ca2+ transient amplitude. Furthermore, Yoda1-induced increment of intracellular Ca2+ could be blocked by the Yoda1 analog Dooku1 or the Piezo1 inhibitor GsMTx4 (Fig. 3F to H).
To comprehensively understand the role of Piezo1 in regulating calcium handling in cardiomyocytes, we measured the intra-SR Ca2+ content following the train of stimulation of calcium transient. After reaching 1 Hz, the SR Ca2+ stores were opened with a rapid application of caffeine (10 mM). The total SR Ca2+ content was comparable between Piezo1Cko and Piezo1fl/fl cardiomyocytes (Fig. 3I and J).
It has been described that the hypersensitive and “leaky” ryanodine receptor (RyR2) could generate spontaneous Ca2+ release [20]. To assess this feature, we used a protocol as previously described [21]. Briefly, after a train of stimuli, pacing is stopped, and the bath medium is rapidly changed for a solution without Na+ and Ca2+ (0 Na–0 Ca) to rule out the influences of sarcolemmal channels (Na+ current, Ca2+ current) and the sodium/calcium exchanger. Thus, the Ca2+ release evoked is the consequence of activated RyR2 channels in diastole. Spontaneous Ca2+ release events were observed in both Piezo1Cko and Piezo1fl/fl cardiomyocytes. However, the number of waves witnessed was significantly higher in the Piezo1fl/fl group pretreated with Yoda1 compared with the Piezo1Cko group (Fig. 3K and L).
Notably, the survival rate was significantly decreased to 73.33% in the Piezo1fl/fl mice within 1 week and continuously dropped to 66.67% up to 6 weeks (die/total 5/15), while the Piezo1Cko mice mostly survived throughout the observation (die/total 1/13) (Fig. 4A). Malignant arrhythmia is a key primary cause of death in mice subjected to MI [22]. To further examine whether Piezo1 was involved in electrical instability after MI, programmed electrical stimulation (PES) was utilized. PES induces sustained ventricular tachycardia (VT), which can be aggravated by isoproterenol (ISO) injection. The survival rate was only 16.67% in Piezo1fl/fl mice with MI when subjected to PES (Fig. 4B and C). Interestingly, Piezo1Cko mice with MI showed high resistance to PES (Fig. 4B and C). Furthermore, ISO greatly increased the incidence and duration of sustained VT and arrhythmia score in Piezo1fl/fl mice with MI (Fig. 4D to F). Piezo1Cko and Piezo1fl/fl mice did not exhibit differences in heart rate, electrocardiogram (ECG) parameters, at baseline, or in response to ISO after MI modeling (Table S4). Besides, direct activation of Piezo1 by its specific agonist Yoda1 through intramyocardial injection led to a typical fishhook-like depression in the ST-T segment in mouse ECG (Fig. 4G), suggesting abnormalities in repolarization. The QRS and QT intervals were also obviously prolonged in the group under Yoda1 stimulation (QRS: Yoda1 30.53 ± 0.63 ms vs. PBS 23.52 ± 1.01 ms, QT: Yoda1 72.88 ± 1.77 ms vs. PBS 53.16 ± 3.38 ms) (Fig. 4H and I), suggesting that Piezo1 activation was attributed to the electrical instability of the heart.
To profile the proteomes of Piezo1fl/fl and Piezo1Cko hearts after MI, mass spectrometry was applied to detect the heart tissue at week 6 after MI. Overall, proteins enriched in mitochondrial translation, adenosine triphosphate (ATP) binding, and oxidoreductase were up-regulated, while proteins enriched in metal ion binding, especially calcium binding, were down-regulated after Piezo1 deletion (Fig. 5A and B). At the myocyte level, currents of sodium, calcium, and potassium channels underlying the ventricular action potential were the molecular mechanisms of arrhythmogenesis (Fig. 5C). However, Piezo1 deletion did not alter the expression of key ion channels in action potential generation and gap junction, including Nav1.5 (SCN5A), Cav1.2 (CACNA1C), Kir6.2 (KCNJ11), Kv7.1(KCNQ1), and connexin43 (GJA1) (Fig. 5D and Fig. S3A to D), but affected the sensitization of the ryanodine receptor (RyR2), which may result in arrhythmias [23]. Phosphorylation of RyR2 at Ser2814 [site for calcium/calmodulin-dependent protein kinase II (CaMKII) activation] triggers the increased diastolic SR Ca2+ leak and provokes cardiac arrhythmias [24]. In Piezo1fl/fl mice, the phosphorylated level of RyR2 at Ser2814 was enhanced after MI, while it was significantly inhibited in Piezo1Cko mice (Fig. 5E). Consistently, Ca2+-dependent regulators/kinases such as calpain7 (CAPN7) and calcium/calmodulin-dependent protein kinases (CaMKs) were significantly decreased in Piezo1Cko hearts, while several critical proteins against apoptosis and oxidative stress like Fas apoptotic inhibitory molecule (FAIM) and mitogen-activated protein kinase 12 (MAPK12) were elevated (Fig. 5F), suggesting that Ca2+-modulated signaling was suppressed after Piezo1 deletion. By applying the neonatal rat cardiomyocytes, we confirmed that Piezo1 activation by Yoda1 could enhance the activity of CaMKII and calpain in a dose-dependent manner (Fig. S4A and B). Moreover, we found that the action potential of mouse cardiomyocytes was dramatically shortened within Yoda1 stimulation, while it was blocked after KN93 (CaMKII inhibitor) incubation (Fig. 5G).
To further confirm whether Piezo1 affects the Ca2+-related signaling at the transcriptional level, we applied RNA sequencing to profile the transcriptomes of Piezo1fl/fl and Piezo1Cko hearts at week 6 after MI. As shown in the Venn diagram and the volcano map, 1356 genes were differentially expressed between MI-operated Piezo1Cko and Piezo1fl/fl groups, including 1095 down-regulated genes and 261 up-regulated genes (Fig. 6A and B). Genes enriched in calcium ion binding, ion transport, and metal ion binding were mostly down-regulated after MI due to Piezo1 deletion (Fig. 6C and D), including CaMKII and calpains (Fig. 6E), which was consistent with the mass spectrometry results.
Taken together, these data suggested that Piezo1 perturbed calcium homeostasis by mediating the intracellular Ca2+ overload and increased the activation of Ca2+-modulated signaling, CaMKII, and calpain, leading to the enhancement of phosphorylation of RyR2 and further increment of Ca2+ leaking, which finally provoked cardiac arrhythmias.
To further verify the arrhythmogenic effect of Piezo1 in human beings, the human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were employed. hiPSC-CM was an ideal approach, which can recapitulate inherited arrhythmia syndromes at the cellular level [25,26]. We first identified the location of Piezo1 by costaining with α-actinin in hiPSC-CMs. Given that hiPSC-CMs exhibit an immature phenotype, Piezo1 was predominantly located at the cytoplasmic membrane (Fig. 7A). Although activation of Piezo1 under Yoda1 stimulation in hiPSC-CMs did not change the resting membrane potential, it distinctively accelerated the action potential rate in a Yoda1 dose-dependent manner (Fig. 7B and C). Meanwhile, action potential durations (APDs) including APD50, APD70, and APD90 were progressively shortened in parallel with the increased Yoda1 concentration, implicating that Piezo1 activation could shorten the repolarization process of action potential (Fig. 7D and Table S5). APD was a critical parameter to assess the arrhythmic risk. Excessive shortened or prolonged action potential with over 20% alteration of APD90 has been proven proarrhythmic [27]. Compared with hiPSC-CMs without Yoda1 stimulation, the hiPSC-CMs stimulated within 1 μM Yoda1 showed a 15.07% ± 2.32% reduction of APD90. The reduction degree kept climbing to 44.64% ± 3.30% and 43.85% ± 2.77% within 5 and 10 μM Yoda1 stimulation, respectively (Fig. 7E). Exaggerated repolarization instability was also observed in hiPSC-CMs with Yoda1 stimulation (5 and 10 μM) (Fig. S5), showing a remarkably aggravation of arrhythmogenic risk.
Triggered activity resulting from the premature activation by afterdepolarizations is associated with shortening or prolonging in APDs [28]. Early afterdepolarizations (EADs), developing before full repolarization at phase 2 or phase 3 of cardiac action potential, is one of the major mechanisms driving arrhythmogenesis in diverse etiologies. Surprisingly, persistent activation of Piezo1 by a progressively increasing concentration gradient of Yoda1 resulted in EADs and further continuous triggered activity in hiPSC-CMs (Fig. 7F). APD was rapidly shortened within 1 min after Yoda1 concentration increased to 1 μM (Fig. 7G and H). Then, persistent triggered activity was observed followed by EADs (Fig. 7I). As time went on, the incidence of triggered EADs gradually decreased, which was supposed to be attributable to the exhausted extracellular Ca2+ or Piezo1 deactivation (Fig. 7J and K). Action potentials ultimately returned to normal after Yoda1 washout (Fig. 7L). These data suggested that activation of Piezo1 results in triggered activity, which underlies the arrhythmogenesis induced after MI.
Although the mortality has greatly declined after application of early reperfusion in patients with acute MI, the survivors remain at high risk of SCD over the subsequent weeks to years despite extensive pharmacotherapy of secondary prevention. The prevalence of SCD is especially high in the first year following MI, which is a vulnerable period of heart [29]. During the remodeling process after MI, wall thickness is heterogeneously distributed over the ventricle, resulting in a regional modulation of a mechanical stimulus so that regional strain alters. These structural heterogeneities further attribute to stretch-induced ventricular arrhythmia [30]. However, the underlying mechanism is poorly understood. In the present study, we uncovered a previously unrecognized role of the mechanosensitive ion channel Piezo1 in the electrical remodeling after MI and its arrhythmogenic effect on cardiomyocyte through Ca2+ handling, showing dramatic prospects in therapeutic approaching SCD and heart failure within cardiac injury.
Piezo1 is a stretch-activated cation channel with preference to Ca2+. It is a critical sensor regulating mechano-chemo-transduction in vasculature, while its role in heart, especially under pathological condition, is unclear. We observed that Piezo1 majorly locates at the intercalated disk and T-tubules. Deletion of Piezo1 in cardiomyocyte preserved the long-term cardiac function and survival rate after MI. Notably, this effect seemed less associated with fibrotic remodeling evidenced by the comparable fibrotic gene expression and scarring area. Cardiac contractility is determined by the cyclic movement of calcium among the extracellular space, cytoplasm, and SR. This Ca2+ handling attributes for the excitation–contraction coupling in cardiomyocytes. SERCA2 is a critical protein involved in sequestration of Ca2+ into SR during diastole, linking contractile force with excitation–contraction coupling. The reduced SERCA2 gene expression and protein level are commonly witnessed in ischemic or failing myocardium, attributing to dysfunction of SR Ca2+ uptake and weakened cardiac contraction [31]. We observed that transient activation of Piezo1 in cardiomyocyte accelerates SR Ca2+ uptake on account for the increased intracellular Ca2+ flux. However, Piezo1 deletion in cardiomyocyte preserved the long-term SERCA2 expression after MI, suggesting that sustained activation of Piezo1 after MI down-regulates SERCA2 expression. The inhibitory effect may blame for Ca2+ overload-induced imbalanced homeostasis of ROS signaling [12], which has been proven to reduce SERCA2 expression [32]. In addition, SERCA2 was capable of interacting directly with Piezo1 by strategically binding to its linker region and further suppressing Piezo1-mediated mechanosensitive currents [33]. On the reverse side, it was suspected that deletion of Piezo1 may preserve the activity of SERCA2 through structural variation.
In addition to SR Ca2+ uptake dysfunction, Ca2+ overload triggers spontaneous Ca2+ leak from SR as well. Given that RyR2 in SR has a finite open probability even at diastolic [Ca2+]i, Ca2+ will leak out of SR, resulting in the occurrence of intracellular Ca2+ waves so that Ca2+ spreads beyond the original sites and elicits arrhythmogenic afterdepolarizations [18]. Our data illustrated that Piezo1 activation after MI promotes the phosphorylation of RyR2, which is evidenced to vary the sensation of RyR2 and increase diastolic SR Ca2+ leakage [34]. Potential mechanism could be attributed from Piezo1-enhanced activity of CaMKII, which is crucial to phosphorylate RyR2 and contribute to a further destabilization of RyR2 [35,36]. At the cellular level, Piezo1 activation triggered arrhythmogenic remodeling through remarkably shortening APD and inducing EADs, which occurs late in phase 3 of action potential. An abbreviated APD permits normal Ca2+ release from SR. However, when the [Ca2+]i keeps rising until the membrane potential is negative to the equilibrium potential for the Na+/Ca2+ exchanger (NCX), INCX will be activated, causing membrane depolarization. These late EADs are clinically relevant with tachycardia including atrial tachycardia, VT, and ventricular fibrillation [37]. In compliance with our data, triggered activity defined by continuous EADs could be seen under the sustained but not evanescent activation of Piezo1. Furthermore, as a nonselective cationic channel, Piezo1 conducts Na+ influx as well. Raised intracellular Na+ could consequently activate the reverse mode of NCX to increase [Ca2+]i [38]. In summary, the above inferences pointed the possible mechanism in the occurrence of arrhythmia linked to Piezo1Cko mice after MI.
Our study demonstrated that Piezo1 is critically involved in arrhythmogenic remodeling after MI through Ca2+ regulation and revealed it as a new potential anti-arrhythmic target in the treatment of MI and heart failure.
The detailed methods are available in the Supplementary Materials.
Three nondiseased human hearts were obtained from 3 healthy donors who died from brain-stem bleeding. Four failing hearts were obtained from patients with end-stage DCM who underwent cardiac transplantation. The hearts were collected and flushed with ice-cold cardioplegic solution. Then, parts of the left ventricular myocardium were frozen in liquid nitrogen for protein extraction, and the other parts were fixed in formaldehyde solution for immunohistochemical staining. All subjects were duly informed, and written consent was provided by patients or their relatives. All the human studies were approved by the Human Research Ethics Committee of the Second Affiliated Hospital, Zhejiang University School of Medicine and were performed under the principles of the Declaration of Helsinki.
Piezo1fl/fl mice (Piezo1tm2.1Apat/J) and Myh6-Cre transgenic mice (A1cfTg(Myh6-cre/Esr1*)1Jmk/J) were purchased from Jackson Laboratory. Cardiac-specific Piezo1 knockout mice (Piezo1Cko) were created by crossing Piezo1fl/fl mice with Myh6-Cre mice. Littermates not carrying the Myh6-Cre transgene (Piezo1fl/fl) served as controls. Inducible deletion of Piezo1 in cardiomyocyte was performed in 4-week-old mice by intraperitoneal administration of tamoxifen (75 mg/kg/day, consistent for 5 days).
Eight-week-old mice were subjected to MI modeling as previously described [39]. Briefly, mice were anesthetized with sodium pentobarbital (50 mg/kg intraperitoneally) and then ventilated via tracheal intubations connected to a rodent ventilator. Acute MI was performed by permanent ligation of the left anterior descending coronary artery (LAD) using a 7-0 nylon suture. Sham surgery was performed exactly as above but without LAD ligation. For tissue harvesting, mice were euthanized with sodium pentobarbital (80 mg/kg intraperitoneally) following cervical dislocation, and then hearts were quickly excised after thoracotomy.
All animals were fed a standard laboratory diet and maintained with a 12:12-h light/dark cycle. All animal studies were performed in compliance with guidelines of the Institutional Animal Care and Use Committee at Zhejiang University School of Medicine (zju201308-1-01-085) and the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996).
Data were presented as means ± SEM. For data with small samples, the Mann–Whitney U test was used between the 2 groups. Survival data were exhibited by Kaplan–Meier curves and analyzed by the log-rank test. The other data were confirmed normal distribution by the Kolmogorov–Smirnov test. Statistical differences were then determined by Student’s t test for comparison between 2 groups and analysis of variance (ANOVA) followed by Bonferroni’s multiple comparison test for comparison among 3 or more groups. P < 0.05 was considered statistically significant. Statistical calculations were carried out using GraphPad Prism 8.0.
1.
Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: When is enough enough? Circulation. 2003;108(11):1395–1403.
2.
Franz MR, Burkhoff D, Yue DT, Sagawa K. Mechanically induced action potential changes and arrhythmia in isolated and in situ canine hearts. Cardiovasc Res. 1989;23(3):213–223.
3.
Johnson DM, Antoons G. Arrhythmogenic mechanisms in heart failure: Linking β-adrenergic stimulation, stretch, and calcium. Front Physiol. 2018;9:Article 1453.
4.
Coste B, Mathur J, Schmidt M, Earley TJ, Ranade S, Petrus MJ, Dubin AE, Patapoutian A. Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science. 2010;330(6000):55–60.
5.
Beech DJ, Kalli AC. Force sensing by piezo channels in cardiovascular health and disease. Arterioscler Thromb Vasc Biol. 2019;39(11):2228–2239.
6.
Li J, Hou B, Tumova S, Muraki K, Bruns A, Ludlow MJ, Sedo A, Hyman AJ, McKeown L, Young RS, et al.Piezo1 integration of vascular architecture with physiological force. Nature. 2014;515(7526):279–282.
7.
Ranade SS, Qiu Z, Woo S-H, Hur SS, Murthy SE, Cahalan SM, Xu J, Mathur J, Bandell M, Coste B, et al.Piezo1, a mechanically activated ion channel, is required for vascular development in mice. Proc Natl Acad Sci U S A. 2014;111(28):10347–10352.
8.
Wang S, Chennupati R, Kaur H, Iring A, Wettschureck N, Offermanns S. Endothelial cation channel PIEZO1 controls blood pressure by mediating flow-induced ATP release. J Clin Invest. 2016;126(12):4527–4536.
9.
Rode B, Shi J, Endesh N, Drinkhill MJ, Webster PJ, Lotteau SJ, Bailey MA, Yuldasheva NY, Ludlow MJ, Cubbon RM, et al.Piezo1 channels sense whole body physical activity to reset cardiovascular homeostasis and enhance performance. Nat Commun. 2017;8(1):350.
10.
Retailleau K, Duprat F, Arhatte M, Ranade SS, Peyronnet R, Martins JR, Jodar M, Moro C, Offermanns S, Feng Y, et al.Piezo1 in smooth muscle cells is involved in hypertension-dependent arterial remodeling. Cell Rep. 2015;13(6):1161–1171.
11.
Blythe NM, Muraki K, Ludlow MJ, Stylianidis V, Gilbert H, Evans EL, Cuthbertson K, Foster R, Swift J, Li J, et al.Mechanically activated Piezo1 channels of cardiac fibroblasts stimulate p38 mitogen-activated protein kinase activity and interleukin-6 secretion. J Biol Chem. 2019;294(46):17395–17408.
12.
Jiang F, Yin K, Wu K, Zhang M, Wang S, Cheng H, Zhou Z, Xiao B. The mechanosensitive Piezo1 channel mediates heart mechano-chemo transduction. Nat Commun. 2021;12(1):869.
13.
Zhang Y, Su S-A, Li W, Ma Y, Shen J, Wang Y, Shen Y, Chen J, Ji Y, Xie Y, et al.Piezo1-mediated mechanotransduction promotes cardiac hypertrophy by impairing calcium homeostasis to activate calpain/calcineurin signaling. Hypertension. 2021;78(3):647–660.
14.
Liu C, Raychaudhuri D, Paul B, Chakrabarty Y, Ghosh AR, Rahaman O, Talukdar A, Ganguly D. Cutting edge: Piezo1 mechanosensors optimize human T cell activation. J Immunol. 2018;200(4):1255–1260.
15.
Xie L, Wang X, Ma Y, Ma H, Shen J, Chen J, Wang Y, Su S, Chen K, Xu L, et al.Piezo1 (piezo-type mechanosensitive ion channel component 1)-mediated mechanosensation in macrophages impairs perfusion recovery after hindlimb ischemia in mice. Arterioscler Thromb Vasc Biol. 2023;43(4):504–518.
16.
Wang L, Yu P, Zhou B, Song J, Li Z, Zhang M, Guo G, Wang Y, Chen X, Han L, et al.Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function. Nat Cell Biol. 2020;22(1):108–119.
17.
Martins-Marques T, Hausenloy DJ, Sluijter JPG, Leybaert L, Girao H. Intercellular communication in the heart: Therapeutic opportunities for cardiac ischemia. Trends Mol Med. 2021;27(3):248–262.
18.
Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol. 2008;70:23–49.
19.
Wang Y, Chi S, Guo H, Li G, Wang L, Zhao Q, Rao Y, Zu L, He W, Xiao B. A lever-like transduction pathway for long-distance chemical- and mechano-gating of the mechanosensitive Piezo1 channel. Nat Commun. 2018;9(1):1300.
20.
Fauconnier J, Thireau J, Reiken S, Cassan C, Richard S, Matecki S, Marks AR, Lacampagne A. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2010;107(4):1559–1564.
21.
Shannon TR, Ginsburg KS, Bers DM. Quantitative assessment of the SR Ca2+ leak-load relationship. Circ Res. 2002;91(7):594–600.
22.
Roell W, Klein AM, Breitbach M, Becker TS, Parikh A, Lee J, Zimmermann K, Reining S, Gabris B, Ottersbach A, et al.Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell coupling. Sci Rep. 2018;8(1):7145.
23.
Landstrom AP, Dobrev D, Wehrens X. Calcium signaling and cardiac arrhythmias. Circ Res. 2017;120(12):1969–1993.
24.
Gong D, Chi X, Wei J, Zhou G, Huang G, Zhang L, Wang R, Lei J, Chen SRW, Yan N. Modulation of cardiac ryanodine receptor 2 by calmodulin. Nature. 2019;572(7769):347–351.
25.
Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, Dorn T, Goedel A, Höhnke C, Hofmann F, et al.Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med. 2010;363(15):1397–1409.
26.
Yazawa M, Hsueh B, Jia X, Pasca AM, Bernstein JA, Hallmayer J, Dolmetsch RE. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature. 2011;471(7337):230–234.
27.
Hondeghem LM, Carlsson L, Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation. 2001;103(15):2004–2013.
28.
Patterson E, Lazzara R, Szabo B, Liu H, Tang D, Li YH, Scherlag BJ, Po SS. Sodium-calcium exchange initiated by the Ca2+ transient: An arrhythmia trigger within pulmonary veins. J Am Coll Cardiol. 2006;47(6):1196–1206.
29.
Docherty KF, Ferreira JP, Sharma A, Girerd N, Gregson J, Duarte K, Petrie MC, Jhund PS, Dickstein K, Pfeffer MA, et al.Predictors of sudden cardiac death in high-risk patients following a myocardial infarction. Eur J Heart Fail. 2020;22(5):848–855.
30.
Seo K, Inagaki M, Nishimura S, Hidaka I, Sugimachi M, Hisada T, Sugiura S. Structural heterogeneity in the ventricular wall plays a significant role in the initiation of stretch-induced arrhythmias in perfused rabbit right ventricular tissues and whole heart preparations. Circ Res. 2010;106(1):176–184.
31.
Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res. 1998;37(2):279–289.
32.
Schultz JJ, Glascock BJ, Witt SA, Nieman ML, Nattamai KJ, Liu LH, Lorenz JN, Shull GE, Kimball TR, Periasamy M. Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity. Am J Physiol Heart Circ Physiol. 2004;286:H1146–H1153.
33.
Zhang T, Chi S, Jiang F, Zhao Q, Xiao B. A protein interaction mechanism for suppressing the mechanosensitive piezo channels. Nat Commun. 2017;8(1):1797.
34.
Fischer TH, Herting J, Tirilomis T, Renner A, Neef S, Toischer K, Ellenberger D, Förster A, Schmitto JD, Gummert J, et al.Ca2+/calmodulin-dependent protein kinase II and protein kinase a differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology. Circulation. 2013;128(9):970–981.
35.
Sadredini M, Haugsten HM, Frisk M, Louch WE, Lehnart SE, Sjaastad I, Stokke MK. CaMKII inhibition has dual effects on spontaneous Ca2+ release and Ca2+ alternans in ventricular cardiomyocytes from mice with a gain-of-function RyR2 mutation. Am J Physiol Heart Circ Physiol. 2021;321(2):H446–H460.
36.
Di Carlo MN, Said M, Ling H, Valverde CA, De Giusti VC, Sommese L, Palomeque J, Aiello EA, Skapura DG, Rinaldi G. CaMKII-dependent phosphorylation of cardiac ryanodine receptors regulates cell death in cardiac ischemia/reperfusion injury. J Mol Cell Cardiol. 2014;74:274–283.
37.
Liaquat MT, Makaryus AN. Cardiac electrical and structural remodelingTreasure Island (FL): StatPearls Publishing; 2023.
38.
Li S-Z, Wu F, Wang B, Wei G-Z, Jin Z-X, Zang Y-M, Zhou J-J, Wong T-M. Role of reverse mode Na+/Ca2+ exchanger in the cardioprotection of metabolic inhibition preconditioning in rat ventricular myocytes. Eur J Pharmacol. 2007;561(1–3):14–22.
39.
Su S-A, Yang D, Wu Y, Xie Y, Zhu W, Cai Z, Shen J, Fu Z, Wang Y, Jia L, et al.EphrinB2 regulates cardiac fibrosis through modulating the interaction of Stat3 and TGF-β/Smad3 signaling. Circ Res. 2017;121(6):617–627.
Year 2023 volume 6 Issue 6
PDF
70
37
Cite this Article
BibTeX
Article Info
doi: 10.34133/research.0165
  • Receive Date:2022-02-14
  • Online Date:2026-10-28
  • Published:2023-06-20
Article Data
Affiliations
History
  • Received:2022-02-14
  • Accepted:2023-05-17
Affiliations
    1Department of Cardiology, Cardiovascular Key Laboratory of Zhejiang Province, The Second Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou 310009, China.
    2Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
    3Texas Heart Institute, Houston, TX 77030, USA.

Corresponding:

* Address correspondence to: (M.X.)
References
Share
https://castjournals.cast.org.cn/joweb/research/EN/10.34133/research.0165
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT